LEADS BIOLABS-B (09887) recommends adopting an H-share reward plan.
Vanguard-B (09887) issued a notice to approve the proposal to adopt H-share incentives on November 25, 2025.
LEADS BIOLABS-B(09887) announced that on November 25, 2025, the proposed H share incentive plan was reviewed and approved. The H share incentive plan aims to: promote the achievement of the company's long-term sustainable development and performance goals; closely link the interests of the grantee with those of shareholders, investors, and the company, thereby enhancing the cohesion of the company and maximizing its value; and improve the company's incentive mechanism to attract, motivate, and retain board members, senior management, and employees who make significant contributions to the company's continued operation, development, and long-term growth.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


